Press Releases

February 5, 2019 Lupin launches Clomipramine Hydrochloride Capsules USP

February 1, 2019 Lupin Announces Launch of Orphan Drug NaMuscla® in Germany and the UK for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

January 28, 2019 U.S. FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility

January 21, 2019 Lupin receives FDA approval for Levothyroxine Sodium Tablets USP

January 18, 2019 LupinLife’s Corcal Bone & Beauty to launch at Lakme Fashion Week with an initiative to bring #Beautifullystrong real women to the ramp

January 8, 2019 Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

January 7, 2019 Lupin receives FDA approval for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg

January 7, 2019 Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

December 31, 2018 Lupin receives FDA approval for Clobazam Oral Suspension, 2.5 mg/mL